- Home
- EVC vs AMRN Comparison
EVC vs AMRN Comparison
Compare EVC & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- AMRN
- Stock Information
- Founded
- EVC 1996
- AMRN 1989
- Country
- EVC United States
- AMRN Ireland
- Employees
- EVC N/A
- AMRN N/A
- Industry
- EVC Broadcasting
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- EVC Industrials
- AMRN Health Care
- Exchange
- EVC Nasdaq
- AMRN Nasdaq
- Market Cap
- EVC 188.3M
- AMRN 216.0M
- IPO Year
- EVC 2000
- AMRN 1993
- Fundamental
- Price
- EVC $2.35
- AMRN $15.85
- Analyst Decision
- EVC
- AMRN Strong Sell
- Analyst Count
- EVC 0
- AMRN 1
- Target Price
- EVC N/A
- AMRN $12.00
- AVG Volume (30 Days)
- EVC 249.5K
- AMRN 171.2K
- Earning Date
- EVC 08-07-2025
- AMRN 07-30-2025
- Dividend Yield
- EVC 8.53%
- AMRN N/A
- EPS Growth
- EVC N/A
- AMRN N/A
- EPS
- EVC N/A
- AMRN N/A
- Revenue
- EVC $378,623,000.00
- AMRN $214,112,000.00
- Revenue This Year
- EVC $64.06
- AMRN N/A
- Revenue Next Year
- EVC N/A
- AMRN N/A
- P/E Ratio
- EVC N/A
- AMRN N/A
- Revenue Growth
- EVC 23.10
- AMRN N/A
- 52 Week Low
- EVC $1.58
- AMRN $7.08
- 52 Week High
- EVC $2.73
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- EVC 49.68
- AMRN 58.98
- Support Level
- EVC $2.19
- AMRN $15.43
- Resistance Level
- EVC $2.60
- AMRN $16.21
- Average True Range (ATR)
- EVC 0.09
- AMRN 0.68
- MACD
- EVC -0.02
- AMRN -0.25
- Stochastic Oscillator
- EVC 16.67
- AMRN 30.10
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.